Doliver Advisors LP Increases Stock Holdings in CME Group Inc (NASDAQ:CME)

Doliver Advisors LP lifted its stake in CME Group Inc (NASDAQ:CME) by 18.9% in the second quarter, according to its most recent disclosure with the …

CME Group logoDoliver Advisors LP lifted its stake in CME Group Inc (NASDAQ:CME) by 18.9% in the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 4,400 shares of the financial services provider’s stock after purchasing an additional 698 shares during the quarter. Doliver Advisors LP’s holdings in CME Group were worth $854,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Ballentine Partners LLC bought a new position in CME Group during the second quarter valued at approximately $313,000. Wetherby Asset Management Inc. raised its position in CME Group by 2.8% during the second quarter. Wetherby Asset Management Inc. now owns 5,287 shares of the financial services provider’s stock valued at $1,026,000 after acquiring an additional 145 shares in the last quarter. Appleton Partners Inc. MA raised its position in CME Group by 1.3% during the second quarter. Appleton Partners Inc. MA now owns 15,289 shares of the financial services provider’s stock valued at $2,968,000 after acquiring an additional 190 shares in the last quarter. Royal Bank of Scotland Group PLC raised its position in CME Group by 1.3% during the second quarter. Royal Bank of Scotland Group PLC now owns 75,702 shares of the financial services provider’s stock valued at $14,695,000 after acquiring an additional 960 shares in the last quarter. Finally, Arizona State Retirement System raised its position in CME Group by 1.1% during the second quarter. Arizona State Retirement System now owns 127,055 shares of the financial services provider’s stock valued at $24,663,000 after acquiring an additional 1,357 shares in the last quarter. 85.72% of the stock is owned by institutional investors and hedge funds.

Several brokerages recently weighed in on CME. Deutsche Bank raised their price objective on shares of CME Group from $224.00 to $240.00 and gave the company a “buy” rating in a research report on Friday, August 9th. BidaskClub raised shares of CME Group from a “hold” rating to a “buy” rating in a research report on Friday, August 9th. Zacks Investment Research lowered shares of CME Group from a “hold” rating to a “sell” rating and set a $158.00 price objective on the stock. in a research report on Monday, May 27th. Wells Fargo & Co lifted their price target on shares of CME Group from $176.00 to $200.00 and gave the company a “market perform” rating in a research report on Wednesday, July 3rd. Finally, Barclays lifted their price target on shares of CME Group from $191.00 to $197.00 and gave the company an “overweight” rating in a research report on Thursday, May 23rd. Three equities research analysts have rated the stock with a sell rating, five have issued a hold rating and eight have assigned a buy rating to the company. The company currently has an average rating of “Hold” and a consensus price target of $194.00.

In other CME Group news, Director Daniel R. Glickman sold 500 shares of the business’s stock in a transaction dated Wednesday, August 28th. The stock was sold at an average price of $216.01, for a total transaction of $108,005.00. Following the completion of the sale, the director now directly owns 14,593 shares of the company’s stock, valued at approximately $3,152,233.93. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through the SEC website. Also, Director Timothy S. Bitsberger sold 700 shares of the business’s stock in a transaction dated Tuesday, June 4th. The stock was sold at an average price of $194.35, for a total value of $136,045.00. Following the sale, the director now directly owns 9,421 shares of the company’s stock, valued at $1,830,971.35. The disclosure for this sale can be found here. Insiders sold 76,771 shares of company stock valued at $15,398,375 over the last ninety days. 1.20% of the stock is currently owned by company insiders.

CME Group stock opened at $215.76 on Thursday. The stock has a 50-day simple moving average of $207.88 and a 200 day simple moving average of $188.20. The company has a quick ratio of 1.05, a current ratio of 1.05 and a debt-to-equity ratio of 0.15. CME Group Inc has a 12-month low of $161.05 and a 12-month high of $217.65. The stock has a market capitalization of $75.64 billion, a price-to-earnings ratio of 31.64, a P/E/G ratio of 4.70 and a beta of 0.23.

CME Group (NASDAQ:CME) last released its quarterly earnings results on Wednesday, July 31st. The financial services provider reported $1.76 earnings per share (EPS) for the quarter, beating the Zacks’ consensus estimate of $1.75 by $0.01. CME Group had a return on equity of 9.14% and a net margin of 39.36%. The business had revenue of $1.27 billion during the quarter, compared to analysts’ expectations of $1.27 billion. During the same period in the previous year, the business posted $1.74 earnings per share. The firm’s revenue for the quarter was up 20.1% compared to the same quarter last year. As a group, sell-side analysts anticipate that CME Group Inc will post 6.68 EPS for the current year.

The firm also recently declared a quarterly dividend, which will be paid on Wednesday, September 25th. Investors of record on Tuesday, September 10th will be issued a $0.75 dividend. The ex-dividend date of this dividend is Monday, September 9th. This represents a $3.00 dividend on an annualized basis and a dividend yield of 1.39%. CME Group’s dividend payout ratio is 43.99%.

CME Group Company Profile

CME Group Inc, through its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers a range of products across various asset classes, including futures and options based on interest rates, equity indexes, foreign exchange, energy, agricultural commodities, and metals, as well as fixed income products.

Recommended Story: Purposes and Functions of the Federal Reserve

Institutional Ownership by Quarter for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily – Enter your email address below to receive a concise daily summary of the latest news and analysts’ ratings for CME Group and related companies with MarketBeat.com’s FREE daily email newsletter.

Related Posts:

  • No Related Posts